Journal
ONCOGENE
Volume 28, Issue 47, Pages 4212-4224Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2009.267
Keywords
tumor suppressor genes; histone methyltransferase; DNA demethylating agents; CpG island; colon cancer
Funding
- European Union [HEALTH-F2-2007-200620, LSHG-CT-2006-037415, FIS PI08 1345, I + D + I MCYT08-03]
- Consolider [MEC09-05]
- Departments of the Spanish Government
- Health Department of the Catalan Government
- Spanish Association Against Cancer (AECC)
- FCT (Portuguese Foundation for Science and Technology) [SFRH/BD/11757/2003]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/11757/2003] Funding Source: FCT
- ICREA Funding Source: Custom
Ask authors/readers for more resources
Understanding the mechanisms that link changes in DNA methylation with histone modifications is particularly relevant in the case of tumor suppressor genes that undergo transcriptional silencing in cancer cells in association with promoter CpG island hypermethylation. In this study, we show that two histone lysine methylation marks associated with active transcription, dimethylation of H3K79 (H3K79me2) and trimethylation of H3K4 (H3K4me3), are present in all the unmethylated promoters analysed, and both of them are lost when these promoters become hypermethylated. Most importantly, pharmacological and genetic interventions that cause DNA demethylation and partial recovery of gene transcription, result in the restoration of H3K4me3, but not of H3K79me2. We also show that DOT1L, the major H3K79 histone methyltransferase, is no longer recruited to the promoters that are demethylated after 5-azadeoxycytidine treatment or genetic deletion of DNA methyltransferases. Knock-down and transfection experiments for DOT1L show that this enzyme has a direct role in maintaining the euchromatic and active status of these genes when unmethylated. These findings suggest that DNA demethylating interventions alone are not able to restore a complete euchromatic status and a full transcriptional reactivation of the epigenetically silenced tumor suppressor genes, and reinforce the necessity of targeting multiple elements of the epigenetics machinery for a successful treatment of malignancies. Oncogene (2009) 28, 4212-4224; doi: 10.1038/onc.2009.267; published online 7 September 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available